Constantino Michael T. - 29 Mar 2023 Form 4 Insider Report for 9 METERS BIOPHARMA, INC.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 29 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Mar 2023, 16:07:09 UTC
Prior SEC filing: 23 Jun 2022
Next SEC filing: 19 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Bethany Sensenig, as power of attorney

Key filing fact

Constantino Michael T. filed Form 4 for 9 METERS BIOPHARMA, INC. on 31 Mar 2023.

Key facts

This page summarizes Constantino Michael T.'s Form 4 filing for 9 METERS BIOPHARMA, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Mar 2023, 16:07.

Change

Previous filing in this sequence was filed on 23 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NMTR transaction

Common Stock

Award

Transaction value
Shares: +7,885
Change %: +261%
Price
Shares after: 10,911
Date: 29 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents Restricted Stock Units ("RSUs") granted pursuant to the 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting date. The RSUs vest as follows: 3,943 shares vest on April 15, 2023 and 3,942 shares vest on December 31, 2023. The vesting of the December 31, 2023 RSUs will accelerate upon a Change in Control prior to December 31, 2023.